Eight Weeks of Treatment With Glecaprevir/Pibrentasvir Is Safe and Efficacious in an Integrated Analysis of Treatment-Naïve Patients With Hepatitis C Virus Infection
2020 ◽
Vol 18
(11)
◽
pp. 2544-2553.e6
◽
Keyword(s):
Keyword(s):
2009 ◽
Vol 21
(3)
◽
pp. 245-253
◽
2015 ◽
Vol 30
(6)
◽
pp. 1049-1056
◽
Keyword(s):
Keyword(s):
2016 ◽
Vol 64
(2)
◽
pp. S769-S770
◽
Keyword(s):
Keyword(s):
Keyword(s):